Stock Analysis

Hextar Healthcare Berhad Third Quarter 2024 Earnings: RM0.004 loss per share (vs RM0.01 loss in 3Q 2023)

KLSE:HEXCARE
Source: Shutterstock

Hextar Healthcare Berhad (KLSE:HEXCARE) Third Quarter 2024 Results

Key Financial Results

  • Revenue: RM30.4m (down 33% from 3Q 2023).
  • Net loss: RM4.06m (loss narrowed by 59% from 3Q 2023).
  • RM0.004 loss per share (improved from RM0.01 loss in 3Q 2023).
earnings-and-revenue-history
KLSE:HEXCARE Earnings and Revenue History November 29th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Hextar Healthcare Berhad shares are down 2.8% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 3 warning signs for Hextar Healthcare Berhad (1 is a bit unpleasant!) that you need to be mindful of.

Valuation is complex, but we're here to simplify it.

Discover if Hextar Healthcare Berhad might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.